Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis

This publication has 15 references indexed in Scilit:

• The G20210A Mutation of the Prothrombin Gene in Patients with Previous First Episodes of Deep-Vein Thrombosis
  Thrombosis Research, 1999
• The VITA Project: Prothrombin G20210A Mutation and Venous Thromboembolism in the General Population
  Thrombosis and Haemostasis, 1999
• The Prothrombin 20210A Allele Is the Most Prevalent Genetic Risk Factor for Venous Thromboembolism in the Spanish Population
  Thrombosis and Haemostasis, 1998
• Factor V Leiden Prevalence in Venous Thromboembolism Patients
  Chest, 1997
• A rapid screening method for the factor V Arg506???Gln mutation
  Blood Coagulation & Fibrinolysis, 1995
• Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
  New England Journal of Medicine, 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
  Proceedings of the National Academy of Sciences, 1993
• Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism
  European Journal of Nuclear Medicine and Molecular Imaging, 1990
• Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism
  BMJ, 1971